Interestingly, both biglycan and aggrecan, two proteoglycans altered in MSS, have been associated with spondyloepimetaphyseal dysplasia, spondyloepiphyseal dysplasia, and chondrodysplastic dwarfism [55, 56]. This evidence concerns the gene ACAN and spondyloepimetaphyseal dysplasia.